Send feedback

TNC p.Arg322Gln

c.965G>A · rs145315080 · VCV1318379

Conflicting classifications of pathogenicity Conflicting submitters
Classification
Conflicting classifications of pathogenicity
ClinVar
Review
Conflicting submitters ★☆☆☆
ClinVar · 4 submitters
AlphaMissense
likely benign
0.1386 · ACMG-weighted
gnomAD v4.1
Rare
ultra-rare (popmax 0.0691%, eas)
Missense predictors
0/3 damaging
AlphaMissense, REVEL, SaProt

Computational evidence

Protein change
AlphaMissense0.1386likely benign
REVEL0.163moderately benign-leaning
SaProtLLR -6.69tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI<0.2no splice effect predicted · four deltas, not one · how we know
Constraint at this position
ConservationphyloP 6phastCons 1
Regional constrainto/e 1.01unconstrained · MANE · 61 kb · p 0.8 · regional, not allelic
Overall
CADD25.6PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0691% East Asian · 31/44,882 alleles
Filtering AF 0.05% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.0435%
Overall 0.00644% 104/1,613,810 alleles · ultra-rare exomes 94/1,461,506 · genomes 10/152,304 · joint denominator
Ancestry group Frequency 1 in
Remaining individualsnot grpmax-eligible 0.0736% 1,359
East Asiangrpmax 0.0691% 1,448
Middle Eastern 0.0165% 6,062
Ashkenazi Jewishnot grpmax-eligible 0.0101% 9,869
South Asian 0.00769% 13,012
Admixed American 0.00333% 30,013
Finnishnot grpmax-eligible 0.00157% 63,682
African / African-American 0.00133% 75,034
European (non-Finnish) 0.00102% 98,335

Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
TNC
Protein
p.Arg322Gln
Coding
c.965G>A
MANE Select
NM_002160
dbSNP
rs145315080
Type
single nucleotide variant
Location
chr9:115086766 (GRCh38)
Gene constraint
LOEUF 0.608 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 75.48 · 21 PDB
Residue 322
the egf-like 6 domain
Full TNC gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/tnc-p-arg322gln (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown